1. Home
  2. CTOS vs NVAX Comparison

CTOS vs NVAX Comparison

Compare CTOS & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Custom Truck One Source Inc.

CTOS

Custom Truck One Source Inc.

HOLD

Current Price

$10.00

Market Cap

1.5B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.01

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTOS
NVAX
Founded
1988
1987
Country
United States
United States
Employees
2500
749
Industry
Diversified Commercial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
CTOS
NVAX
Price
$10.00
$8.01
Analyst Decision
Buy
Hold
Analyst Count
5
9
Target Price
$9.30
$11.33
AVG Volume (30 Days)
985.9K
2.8M
Earning Date
04-27-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
N/A
$1,123,479,000.00
Revenue This Year
$6.84
N/A
Revenue Next Year
$4.86
N/A
P/E Ratio
N/A
$3.10
Revenue Growth
N/A
64.69
52 Week Low
$3.99
$5.80
52 Week High
$9.90
$11.85

Technical Indicators

Market Signals
Indicator
CTOS
NVAX
Relative Strength Index (RSI) 89.62 40.32
Support Level $5.50 $7.70
Resistance Level N/A $8.45
Average True Range (ATR) 0.34 0.30
MACD 0.21 -0.01
Stochastic Oscillator 96.27 23.05

Price Performance

Historical Comparison
CTOS
NVAX

About CTOS Custom Truck One Source Inc.

Custom Truck One Source Inc is a one-stop-shop provider of specialty equipment in the electric utility transmission and distribution, forestry, telecom, waste management, rail, and infrastructure end-markets in North America. The company's segment includes Equipment Rental Solutions (ERS), Truck and Equipment Sales (TES), and Aftermarket Parts and Services (APS). It generates maximum revenue from the TES segment. Geographically, it derives a majority revenue from the United States.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: